OncoSec Medical Long Term Debt

OncoSec Medical (ONCS) currently reports a long-term debt of $2.1M as of January 2023. That compares with $4.7M in the prior-year period — down 54.8% year over year. Use the charts on this page to explore OncoSec Medical's long-term debt history and peer comparisons.

OncoSec Medical's long-term debt decreased from $4.7M to $2.1M — a 54.8% year-over-year decrease (period ending January 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

OncoSec Medical reported $2.1M in long-term debt as of January 2023. That compares with $4.7M in the prior-year period — down 54.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $2.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for OncoSec Medical, and consider following ONCS for alerts when major investors trade the stock.

OncoSec Medical is classified in the Healthcare sector. On long-term debt, it currently shows $2.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ONCS with unrelated industries.